Stingray Therapeutics

Stingray is a clinical stage biotech company that has developed potent and selective small molecule inhibitors of ENPP1, Ectonucleotide Pyrophosphatase / Phosphodiesterase1.

Country

United States
Visit website (opens in a new tab)
Loading
View All (opens in a new tab)